Statement From the HEART Group

www.ahjonline.com

American Heart Journal

Table of Contents March 2013, Volume 165, Number 3

266 Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: Rationale and design of the MagnaSafe RegistryRobert J. Russo, MD, PhD, La Jolla, CA

273 Central versus local adjudication of myocar-dial infarction in a cardiac biomarker trialStephen W. Smith, MD, Deborah B. Diercks,

MD, MSc, John T. Nagurney, MD, MPH, Judd E. Hollander, MD, Chadwick D. Miller, MD, MS, Jon W. Schrock, MD, Adam J. Singer, MD, Fred S. Apple, PhD, Peter A. McCullough, MD, MPH, Christian T. Ruff, MD, MPH, Arturo Sesma, Jr, PhD, and W. Frank Peacock, MD, Minneapolis, and St Paul, MN; Davis, CA; Boston, MA; Philadelphia, PA; Winston-Salem, NC; Cleveland, OH; Stony Brook, NY; Detroit, MI; and Houston, TX

Transradial Angiography and Intervention

280 Transradial percutaneous coronary intervention in cardiogenic shock: A single-center experienceOriol Rodriguez-Leor, MD, Eduard Fernandez-Nofrerias, MD, Xavier Carrillo, MD, Josepa Mauri, MD, PhD, Carolina Oliete, RN, Maria del Carmen Rivas, RN, and Antoni Bayes-Genis, MD, PhD, Barcelona, Spain

286 Radiation exposure during coronary angiography via transradial or transfemoral approaches when performed by experienced operatorsBinita Shah, MD, MS, Sripal Bangalore, MD, MHA, Frederick Feit, MD, Gregory Fernandez, BS, John Coppola, MD, Michael J. Attubato, MD, and James Slater, MD, New York, NY

American Heart Journal 1A

American Heart Journal (ISSN 0002-8703) is published monthly by Mosby, 360 Park Avenue South, New York, NY 10010-1710. Periodicals postage paid at New York, NY and addi-tional mailing offices. USA POSTMASTER: Send address changes to American Heart Journal, Elsevier Customer Service Department, 3251 Riverport Lane, Maryland Heights, MO 63043, USA.

251 Statement on matching language to the type of evidence used in describing outcomes dataEditors of the HEART Group Journals, Durham, NC.

Editorials

252 Attribution of causality in clinical research: An important element for learning health systemsRobert M. Califf, MD, MACC, Durham, NC

254 Radiation exposure with transradial and transfemoral proceduresSamir B. Pancholy, MD, Olivier F. Bertrand, MD, PhD, Scranton, PA; and Quebec, Canada

256 Improving outcomes in patients with cardiogenic shock: Achieving more through lessIan C. Gilchrist, MD, FACC, FSCAI and Sunil V. Rao, MD, FACC, FSCAI, Hershey, PA; and Durham, NC

Trial Design

258 INtensive versus Standard Ambulatory Blood Pressure Lowering to Prevent Functional DeclINe In The ElderlY (INFINITY)

William B. White, MD, Ravi Marfatia, MD, Julia Schmidt, BA, Dorothy B. Wakefield, MS, Richard F. Kaplan, PhD, Richard W. Bohannon, EdD, Charles B. Hall, PhD, Charles R. Guttmann, MD, Nicola Moscufo, PhD, Douglas Fellows, MD, and Leslie Wolfson, MD, Farmington, Storrs, CT, Boston, MA; and Bronx, NY

2A American Heart Journal

Contents continued

293 Reduction in operator radiation exposure during transradial catheterization and intervention using a simple lead drapeAli F. Iqtidar, MD, Cathy Jeon, MD, MSc, Richard Rothman, MD, Randall Snead, RRT, and Christopher T. Pyne, MD, Burlington, MA

299 Impact of a dedicated “radial lounge” for percutane-ous coronary procedures on same-day discharge rates and bed utilizationShireen Brewster, MBBS, MRCP, Kapil Khimdas, BA, BSCH, Noel Cleary, RN, Angela Penswick, RN, Samantha Cliffe, RN, Roshan Weerackody, MBBS, PhD, MRCP, Andrew Wragg, MBBS, (Hons), PhD, MRCP, Martin T. Rothman, MBBS, FRCP, and R. Andrew Archbold, MBBS, MD, FRCP, London, United Kingdom

303 Comparison of costs between transradial and transfemoral percutaneous coronary interven-tion: A cohort analysis from the Premier

research databaseDavid M. Safley, MD, Amit P. Amin, MD, MSc, John A. House, MS, Dmitri Baklanov, MD, Rebecca Mills, MSM, Helmut Giersiefen, PhD, Andreas Bremer, PhD, and Steven P. Marso, MD, Kansas City, MO; and Charlotte, NC

310 Transradial and transfemoral coronary angiography and interventions: 1-Year outcomes after initiating the transra-dial approach in a cardiology training programChristopher R. Balwanz, MD, Usman Javed, MD, Gagan D. Singh, MD, Ehrin J. Armstrong, MD, Jeffrey A. Southard, MD, Garrett B. Wong, MD, Khung Keong Yeo, MBBS, Reginald I. Low, MD, John R. Laird, Jr, MD, and Jason H. Rogers, MD, Sacramento, CA

317 Influence of access site choice on incidence of neurologic complications after percutaneous coronary interventionKarim Ratib, MB, ChB, Mamas A. Mamas, MD, Helen C. Routledge, MD, Peter F. Ludman, MD, Douglas Fraser, MD, and James Nolan, MD, Stoke-on-Trent, Manchester, Worcester, and Birmingham, United Kingdom

325 Successive transradial access for coronary proce-dures: Experience of Quebec Heart-Lung InstituteEltigani Abdelaal, MD, Pierre Molin, MD, Guillaume Plourde, MS, Jimmy MacHaalany, MD, Yoann Bataille, MD, Cynthia Brousseau-Provencher, MD, Sarah Montminy, MS, Éric Larose, MD, Louis Roy, MD, Onil Gleeton, MD, Gérald Barbeau, MD, Can M. Nguyen, MD, Bernard Noël, MD, Olivier Costerousse, PhD, and Olivier F. Bertrand, MD, PhD, Quebec, Canada

332 The practice of transradial percutaneous coronary inter-vention in the Washington State Clinical Outcomes Assessment ProgramCharles Maynard, PhD, Steven M. Bradley, MD, MPH, and Chris L. Bryson, MD, MS, Seattle, WA; and Denver, CO

338 Early and late outcomes after primary percutaneous coronary intervention by radial or femoral approach in patients presenting in acute ST-elevation myocardial infarction and cardiogenic shockIvo Bernat, MD, PhD, Eltigani Abdelaal, MD, Guillaume Plourde, MS, Yoann Bataille, MD, Jakub Cech, MD, Jan Pesek, MD, Jiri Koza, MD, Stepan Jirous, MD, Jimmy Machaalany, MD, Jean-Pierre Déry, MD, Olivier Costerousse, PhD, Richard Rokyta, MD, PhD, and Olivier F. Bertrand, MD, PhD, Pilsen, Czech Republic; and Quebec, Canada

Cardiac Safety Research Consortium

344 TransRadial Education And Therapeutics (TREAT): Shifting the balance of safety and efficacy of antithrombotic agents in percutane-

ous coronary intervention. A report from the Cardiac Safety Research ConsortiumConnie N. Hess, MD, Sunil V. Rao, MD, David F. Kong, MD, Julie M. Miller, MD, Kevin J. Anstrom, PhD, Olivier F. Bertrand, MD, Jean-Philippe Collet, MD, Mark B. Effron, MD, Benjamin C. Eloff, PhD, Emmanuel O. Fadiran, PhD, Andrew Farb, MD, Ian C. Gilchrist, MD, David R. Holmes, MD, Alice K. Jacobs, MD, Prashant Kaul, MD, L. Kristin Newby, MD, MHS, David R. Rutledge, PharmD, Dale R. Tavris, MD, MPH, Thomas T. Tsai, MD, MSc, Roseann M. White, MA, Eric D. Peterson, MD, MPH, and Mitchell W. Krucoff, MD, FACC, FCCP, Durham, and Chapel Hill, NC; Baltimore, and Silver Spring, MD; Quebec, Canada; Paris, France; Indianapolis, IN; Hershey, PA; Rochester, MN; Boston, MA; San Francisco, CA; and Denver, CO

American Heart Journal 3A

Contents continued

Continued on page 4A

Clinical Investigations

Acute Ischemic Heart Disease354 Dynamic modeling of 90-day mortality in ST-

elevation myocardial infarction patients under-going primary percutaneous coronary intervention

Cynthia M. Westerhout, PhD, Karen S. Pieper, MS, Stefan K. James, MD, PhD, Kenneth W. Mahaffey, MD, Frans Van de Werf, MD, PhD, Robert M. Califf, MD, MACC, Christopher B. Granger, MD, and Paul W. Armstrong, MD, Alberta, Canada; Durham, NC; Uppsala, Sweden; and Leuven, Belgium

363 Prehospital system delay in ST-segment elevation myo-cardial infarction care: A novel linkage of emergency medicine services and inhospital registry dataEmil L. Fosbøl, MD, PhD, Christopher B. Granger, MD, Eric D. Peterson, MD, MPH, Li Lin, MS, Barbara L. Lytle, MS, Frances S. Shofer, PhD, Chad Lohmeier, MBA, Greg D. Mears, MD, J. Lee Garvey, MD, Claire C. Corbett, MMS, NREMT-P, James G. Jollis, MD, and Seth W. Glickman, MD, Durham, Chapel Hill, Charlotte, and Wilmington, NC

371 Risk stratification in patients with unstable angi-na using absolute serial changes of 3 high-sen-sitive troponin assays

Tobias Reichlin, MD, Raphael Twerenbold, MD, Claudia Maushart, MD, Miriam Reiter, MD, Berit Moehring, MD, Nora Schaub, MD, Cathrin Balmelli, MD, Maria Rubini Gimenez, MD, Rebeca Hoeller, MD, Konstantin Sakarikos, MD, Beatrice Drexler, MD, Philip Haaf, MD, Stefan Osswald, MD, and Christian Mueller, MD, FESC, Basel, Switzerland; and Boston, MA

Congestive Heart Failure379 Incidence of heart failure and mortality after

acute coronary syndromesPadma Kaul, PhD, Justin A. Ezekowitz, MD,

Paul W. Armstrong, MD, Becky K. Leung, Bsc, Anamaria Savu, PhD, Robert C. Welsh, MD, Hude Quan, MD, PhD, Merril L. Knudtson, MD, and Finlay A. McAlister, MD, Alberta, Canada

386 Wearable defibrillators in uninsured patients with newly diagnosed cardiomyopathy or recent revascularization in a community medical centerRaul D. Mitrani, MD, Amanda Mcardle, MSN, ACNP, Michele Slane, CCRN, John Cogan, MD, and Robert J. Myerburg, MD, Miami, and Hollywood, FL

Interventional Cardiology393 Outcome and safety of same-day-discharge percutaneous

coronary interventions with femoral access: A single-center experienceLisbeth Antonsen, MD, Lisette Okkels Jensen, MD, DMSci, PhD, and Per Thayssen, MD, DMSci, Odense, Denmark

400 Characteristics of culprit atheromatous plaques obtained in vivo by intravascular ultrasound radiofre-quency analysis: Results from the CULPLAC studyJosé D. Cascón-Pérez, MD, PhD, José M. de la Torre-Hernández, MD, PhD, FESC, María C. Ruiz-Abellón, MD, PhD, Miryam Martínez-Pascual, MD, Rosario Mármol-Lozano, MD, José López-Candel, MD, PhD, Pedro Cano, MD, Concepción Fernández, MD, José L. Ramos, MD, Manuel Villegas, MD, PhD, and Francisco Picó-Aracil, MD, PhD, Murcia, and Cantabria, Spain

408 Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: A double-blind, randomized, placebo-controlled clinical trialYo Iwata, MD, Yoshihide Fujimoto, MD, Tomoki Morino, MD, Kazumasa Sugimoto, MD, Kenji Ohkubo, MD, Tadayuki Kadohira, MD, Kenichi Fukushima, MD, Hideki Kitahara, MD, Issei Komuro, MD, and Yoshio Kobayashi, MD, Chiba, and Tokyo, Japan

415 Closed versus open cell stent for high-risk percutane-ous coronary interventions in ST-elevation acute myo-cardial infarction: The Closed versus Open Cells stent for High risk percutaneous coronary Interventions in ST-Elevation acute myocardial infarction (COCHISE) pilot studyAlessandro Sciahbasi, MD, Gianluca Pendenza, MD, Luca Golino, MD, PhD, Enrico Romagnoli, PhD, MD, Giorgia Caferri, MD, Roberto Patrizi, MD, Francesco Summaria, MD, Francesco Serra, MD, Maria Benedetta Giannico, MD, Emanuele Bruno, MD, Luigi Sommariva, MD, and Ernesto Lioy, MD, Rome, and Viterbo, Italy

4A American Heart Journal

Contents continued

421 Ischemic stroke associated with left cardiac catheteriza-tion: The importance of modifiable and non-modifiable risk factorsBatric Popovic, MD, Sylvain Carillo, MD, Nelly Agrinier, MD, Charles Christophe, MD, Christine Selton-Suty, MD, Yves Juillière, MD, and Etienne Aliot, MD, Nancy, France

Surgery427 Thrombotic and bleeding complications

after orthopedic surgeryBrandon S. Oberweis, MD, Swetha Nukala,

MBBS, Andrew Rosenberg, MD, Yu Guo, MA, Steven Stuchin, MD, Martha J. Radford, MD, FACC, FAHA, and Jeffrey S. Berger, MD, MS, FAHA, FACC, New York, NY

Outcomes, Health Policy, and Managed Care434 Data quality of an electronic health record tool to

support VA cardiac catheterization laboratory quality improvement: The VA Clinical Assessment, Reporting, and Tracking System for Cath Labs (CART) programJames Brian Byrd, MD, MS, Rebecca Vigen, MD, MPA, Mary E. Plomondon, PhD, MSPH, John S. Rumsfeld, MD, PhD, Tamára L. Box, Stephan D. Fihn, MD, MPH, and Thomas M. Maddox, MD, MSc, Ann Arbor, MI; Denver, CO; and Washington, DC